_________
false
ëï-ôééè áéåôøîä áò"î
2
381
CAN-FITE BIOPHARMA LTD
Corporation no:
512022153
14960
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
26/06/2024
www.isa.gov.il
www.tase.co.il
Reference:
2024-02-065197
Time of broadcast:
15:56
15:56
The corporation scheduled the publication of the report to
26/06/2024 23:15
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
On June 26, 2024, Can-Fite BioPharma Ltd. (the “Company”) convened the Annual General Meeting of Shareholders (the “Annual General Meeting”), however, the Annual General Meeting was adjourned for one week to the same day, time and place due to lack of quorum. Accordingly, the Company’s Annual General Meeting will be reconvened on Wednesday, July 3, 2024 at 3:00p.m., Israel time at the Company’s offices located at 26 Ben Gurion Street, Ramat Gan, Israel.
ea020854001-6k_canfiteEDGAR1_Bannerless_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2024-02-059553
Stock Exchange/Market:
-1
Date of revision of form structure:
18/06/2024
Address:
Bareket
10
,
Petach-Tikva
47190
,
Tel:
03-9241114
,
03-9213501
Fax:
03-9249378
E-mail address:
motti@canfite.co.il
Company site:
www.canfite.com
Previous names of reporting entity:
Name of the Signatory:
FARBSTEIN MORDECHAI
Position of Signatory in the reporting corporation:
Chief Operating Officer & CFO
Name of Employer Company:
Address:
Maharal street
10
,
Tel Aviv
6248110
Telephone:
052-8998671
Facsimile:
E-mail:
Motti@canfite.co.il
1